Utah Medical Products, Inc.
UTMD
$58.72
$0.390.67%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -14.35% | -10.28% | -6.54% | -3.93% | -0.30% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -14.35% | -10.28% | -6.54% | -3.93% | -0.30% |
| Cost of Revenue | -10.09% | -3.62% | 0.56% | 0.51% | 2.85% |
| Gross Profit | -17.11% | -14.39% | -10.91% | -6.70% | -2.24% |
| SG&A Expenses | -37.15% | -27.52% | -17.98% | -8.86% | -1.90% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -18.44% | -11.10% | -5.41% | -2.55% | 1.18% |
| Operating Income | -7.69% | -9.02% | -8.25% | -6.04% | -2.62% |
| Income Before Tax | -11.90% | -11.38% | -6.97% | -2.76% | 2.04% |
| Income Tax Expenses | -21.60% | -20.02% | -17.21% | -17.51% | -10.50% |
| Earnings from Continuing Operations | -9.74% | -9.39% | -4.52% | 0.99% | 5.33% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.74% | -9.39% | -4.52% | 0.99% | 5.33% |
| EBIT | -7.69% | -9.02% | -8.25% | -6.04% | -2.62% |
| EBITDA | -20.41% | -17.08% | -12.46% | -7.09% | -2.18% |
| EPS Basic | -8.18% | -8.79% | -4.37% | 1.25% | 5.82% |
| Normalized Basic EPS | -1.42% | -1.20% | 1.39% | 5.80% | 9.46% |
| EPS Diluted | -8.08% | -8.72% | -4.56% | 1.21% | 5.80% |
| Normalized Diluted EPS | -1.23% | -1.08% | 1.43% | 5.79% | 9.45% |
| Average Basic Shares Outstanding | -1.79% | -0.72% | -0.16% | -0.28% | -0.48% |
| Average Diluted Shares Outstanding | -1.98% | -0.85% | -0.19% | -0.26% | -0.47% |
| Dividend Per Share | 1.69% | 1.70% | 1.71% | 1.72% | 35.63% |
| Payout Ratio | 0.12% | 0.12% | 0.06% | 0.34% | -0.61% |
